At the bulk level, COL10A1 was significantly upregulated in tumor tissues across all nine cancer types examined (Supplementary Fig. 15A) and its high expression was consistently associated with poorer OS, particularly in liver, gastric, breast, prostate, and cervical cancers (Supplementary Fig. 15B). This evidence concerns the gene COL10A1 and cervical carcinoma.